Finally, in patients with lung adenocarcinoma, OPN was identified as a biomarker, and high expression of the protein has been associated with poor patient survival and identified as a predicting tool for disease stage prognosis [96,119]. This evidence concerns the gene SPP1 and lung adenocarcinoma.